Indeed, NK cells exhibit antibody‐dependent cellular cytotoxicity, and various antibodies (eg, CD133 or anti‐NKG2A) have been described to mobilize NK cells against AML cells.126, 127, 128, 129. The gene discussed is PROM1; the disease is acute myeloid leukemia.